Labeler · US market

Pharmaceutical Associates, Inc.

Pharmaceutical Associates, Inc. is a US drug labeler with US FDA registrations covering 8 drug concepts (8 currently active) across 20 packages. It is currently the only active US supplier of 2 drugs.

ACTIVE — US

openFDA · updated weekly

Labeler codes0121

Active drugs8

Registrations12 active / 12

Packages20

Sole supplier of2 drugs

Portfolio8 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Nystatin suspension	rx	2	5	SUPPLYING
Sodium Citrate And Citric Acid Monohydrate solution	rx	2	4	SUPPLYING
Phenobarbital solution	rx	1	4	SUPPLYING
Ibuprofen suspension	rx	2	2	SUPPLYING
Ranitidine syrup	rx	2	2	SUPPLYING
Diazepam solution	rx	1	1	SUPPLYING
Propranolol Hydrochloride solution	rx	1	1	SUPPLYING
Lorazepam liquid	rx	1	1	SUPPLYING

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

Lorazepamrx
Ranitidinerx

At a glance

TypeLabeler
Labeler codes0121
Filing names1
Drugs (active)8
Drugs (all time)8
US registrations12
Packages20

Recent events

Shortages, recalls, and registration changes across all filing names.

Jan 14, 2020
RECALLRecall (Class II): Nystatin Oral Suspension, USP 100,000 units per mL Cherry/Peppermint Flavor, 16 fl oz (473 mL) Rx Only, pai, Pharmaceu…
May 29, 2018
RECALLRecall (Class III): Nystatin Oral Suspension, USP, 500,000 units/5 mL, For Institutional Use Only, packaged in 5 mL cups, Rx Only, Pharmac…
Oct 16, 2014
RECALLRecall (Class II): Cyproheptadine HCl Syrup (Cyproheptadine HCl Oral Solution, USP) 4mg/10 mL, Rx ONLY, Pharmaceutical Associates, Inc., G…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.